ClinicalTrials.gg
Status unknownNCT03327246Updated Oct 31, 2017

CONNECARE-Assuta-Case Study 2

An interventional study of Connecare self managment system in Chronic Disease and Old Age; Debility, sponsored by Assuta Medical Center. Status unknown. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2017-10-31.

Primary conditionChronic Disease(the registry's first term)UnverifiedIs this wrong?Chronic Disease is a broad heading, used only when no more specific condition is named. No better condition is named, so the registry's term is kept.

Sponsored by Assuta Medical Center · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Oct 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
220
Allocation
Non-randomized
Ages
65 Years and older
Sex
All
01

Study summary

The European Union's Horizon 2020 project issued a Call for Action [1] in December 2013 to design, develop, disseminate and evaluate new IT technologies for use in integrative treatment processes, with emphasis on complex adult patient. Assuta Hospital submitted a proposal for this call, as part of a broad consortium of 10 participants from various European countries.

The CONNECARE consortium has formulated a general model for integrative treatment, and is currently in the technological development stages, to create a smart (supportive decision) and adaptive system that supports integrative treatment processes both in the hospital and in the community for personalized treatment in complex chronic patients. The development includes a significant integrative component of self-care management by the patient and / or the primary caregiver.

Following the completion of the technological development, clinical trials will be held in four organizations throughout Europe - Assuta Hospital in Ashdod in cooperation with the Maccabi community in Ashdod, two centers in Catalonia and the Groningen region in the Netherlands. The purpose of the studies is to assess the impact of the implementation of the model, processes and digital tools that will be built during the project.

Read the detailed description

The intervention in this study consists of three parts:

  1. Empowering the patient to self-manage his or her health by using applications for smart devices.
  2. Intensive pre-habilitation plan with close monitoring during the month prior to surgery.
  3. Integrative treatment in the community, which includes a close followup with a coordinating nurse for three months after discharge from the hospital.

The study protocol:

  1. Recruitment of participants after scheduling a major elective surgery, explanation of the study and signing the consent form.
  2. Evaluation process for the patient, using valid questionnaires, in order to determine the baseline level at the entrance to the study.
  3. Distribution of research kit and related accessories and training.
  4. Close monitoring during pre habilitation plan for a month prior to surgery.
  5. Reassessment of the patient after the surgery and before discharge from the hospital.
  6. Close monitoring during three months in the community after discharge from the hospital and use of the research kit.
  7. Reassessment of the patient at the exit of the study.
02

Conditions studied

  • Chronic Disease
  • Old Age; Debility

Browse trials for

03

In context

Chronic Disease Unverified

781 studies on the registry are indexed under Chronic Disease; 144 are open to participants now.

This study's planned enrollment of 220 is above the median of 140 across 582 interventional studies indexed under Chronic Disease.

Browse Chronic Disease studies →

Lead sponsor

Assuta Medical Center is the lead sponsor of 44 studies on the registry; 1 is open to participants now.

Compared within Chronic Disease, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All Maccabi members who were scheduled for a major elective surgery
  • Age over 65
  • Living in a home and not in a nursing home
  • Anesthesiologist evaluation of levels 2 or 3 only
  • Diagnosis of at least one chronic disease of the following - , cardiovascular disease, diabetes, hypertension, cancer or obesity.
  • The patient and / or the main caregiver speak Hebrew, English or Russian
  • The patient or primary caregiver has a password to the Maccabi Online website
  • The patient and / or the primary caregiver have basic technological knowledge in the use of the applications
  • The patient has wireless Internet access at home (via Wifi or through a cellular connection)

Exclusion criteria

Exclusion Criteria:

  • Patients with cognitive or dementia problems
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
220 participants (estimated)

Study arms

  • Experimental
    Intervention group

    Implementing the Connecare system to support integrated care for complex patients who are plan to undergo a major elective surgery in Assuta Ashdod and are discharged back to the community with an emphasis on Connecare self managment system for the patient and close follow up and coordination of all of the medical, health and social care in the community for two periods of time: (1) Pre habilitation plan for a month prior to surgery (2) a period of 3 months post discharge.

    Device: Connecare self managment system

  • No intervention
    No Intervention: Matched control group

    The control group will be selected from Maccabi's database and will be patients who are matched 1:1 with the intervention sample and live in another community similar to Ashdod in socioeconomic characteristics who undergo the same elective major surgery in other hospitals

Interventions

  • DeviceConnecare self managment system

    The CONNECARE SMS will rely on a hybrid solution that, besides being autonomous (the patient may use the SMS to monitor and access to her/his data and information), has also a collaborative component (through the interaction with the SACM) to allow participation by clinicians and to provide feedback to them. In so doing, the patient may control her/his activity, receiving recommendations to improve the treatment and to be encouraged in following it.

06

What researchers measure

Primary outcomes

  1. Length of hospitalization after surgery and complications during and after hospitalization

    Time frame: Less then one month

  2. Re-Hospitalizations and emergency room visits in the short term after discharge from the hospital

    Number of hospitalizations and emergency room visits after discharge

    Time frame: One month

  3. Re-Hospitalizations and emergency room visits in the long term after discharge from the hospital

    Number of hospitalizations and emergency room visits after discharge

    Time frame: One year

  4. Length of hospitalization

    In days

    Time frame: Less then one month

Secondary outcomes

  1. Compliance with the assignments in the discharge program guidelines

    At the time of discharge from the hospital, the patient receives a list of tasks to be performed as part of the release letter. We would like to know how many out of this tasks were carried out

    Time frame: One year

  2. Community health services use

    Number of appointments made by the patient during the follow up time for primary physician, professionals, laboratory tests and imaging, physiotherapy and nutritionist.

    Time frame: One year

  3. Evaluation of usability of the technology systems developed

    Using questionnaires for nurses and patients to express their opinion on the use of the technology systems in the project and how much these systems assisted them

    Time frame: One year

  4. Cost-benefits evaluation for the intervention

    Economic evaluation of tests and services saved as a result of active and orderly monitoring of the patient

    Time frame: One year

  5. Assessment of satisfaction of patients from all the projects components (The follow up and the technology systems)

    Using satisfaction questionnaires to be passed at the end of the study

    Time frame: One year

  6. Assessment of satisfaction of medical staff from all the projects components (The follow up and the technology systems)

    Using satisfaction questionnaires to be passed at the end of the study

    Time frame: One year

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Feb 2018; primary completion for Feb 2019, 12 months later.

Of 318 non-industry interventional studies with no phase under Chronic Disease, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 33. This study's planned 12 months is below that.

Counting every sponsor, half of 328 studies reached it within 21 months; a quarter within 11 and three quarters within 33.

Chronic Disease covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2017
First posted
Oct 31, 2017
StartEst.
Feb 1, 2018
Primary completionEst.
Feb 1, 2019
CompletionEst.
Feb 1, 2019
Last update
Oct 31, 2017
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 31, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03327246
Lead sponsor
Assuta Medical Center
Collaborators
European Commission
Responsible party
Dr Bellaa Azria (Head of Medicine, Assuta Medical Centers, Assuta Medical Center) — Principal investigator
First posted
Oct 31, 2017
Start date
Feb 1, 2018 (estimated)
Primary completion
Feb 1, 2019 (estimated)
Completion
Feb 1, 2019 (estimated)
Last update
Oct 31, 2017

Study contacts

Reut Ron, M.SC
Contact
Reutro@assuta.co.il
+972-542240225
Bella Azaria, Doctor
study director · Assuta Medical Center

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Oct 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion